Literature DB >> 9414053

Stimulation of the greater occipital nerve increases metabolic activity in the trigeminal nucleus caudalis and cervical dorsal horn of the cat.

P J Goadsby1, Y E Knight, K L Hoskin.   

Abstract

Patients with primary headache syndromes often describe a distribution of pain that involves both frontal and occipital parts of the head. Such a distribution of pain does not respect the cutaneous sensory innervation of the head which would divide it into anterior (trigeminally innervated) and posterior (spinal nerve root innervated) regions. Studies of pain-producing intracranial structures, such as the superior sagittal sinus, have demonstrated that second order neurons as caudal as C2 are activated after either electrical or mechanical stimulation. For this study cats were anaesthetised with halothane (during surgery) and alpha-chloralose (60 mg/kg, i.p., then 20 mg/kg intravenous maintenance), paralysed (gallamine 6 mg/kg) and ventilated. The greater occipital nerve was isolated bilaterally and stimulated unilaterally using hook electrodes with stimuli of 100 V at 0.3 Hz. Metabolic activity in the caudal brain stem and upper cervical cord was measured using 2-deoxyglucose autoradiography and quantitative densitometry. Stimulation of the greater occipital nerve increased metabolic activity by 220% ipsilateral to stimulation and by a lesser amount contralaterally. Increases in metabolic activity were seen in the dorsal horn at the level of C1 and C2 as might be predicted from the cervical origin of the nerve. Neuronal activation appeared contiguous with the trigeminal nucleus caudalis and was in the same distribution as is seen when trigeminally-innervated structures are stimulated. These data suggest that the well recognised clinical phenomenon of pain at the front and back of the head and in the upper neck are likely to be a consequence of overlap of processing of nociceptive information at the level of the second order neurons.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9414053     DOI: 10.1016/s0304-3959(97)00074-2

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  30 in total

Review 1.  Blocking the greater occipital nerve: utility in headache management.

Authors:  William B Young
Journal:  Curr Pain Headache Rep       Date:  2010-10

Review 2.  Occipital nerve stimulation for headache disorders.

Authors:  Koen Paemeleire; Thorsten Bartsch
Journal:  Neurotherapeutics       Date:  2010-04       Impact factor: 7.620

Review 3.  Supratrochlear and Supraorbital Nerve Stimulation for Chronic Headache: a Review.

Authors:  Stephanie Wrobel Goldberg; Stephanie J Nahas
Journal:  Curr Pain Headache Rep       Date:  2015-07

Review 4.  Occipital Neuralgia and Cervicogenic Headache: Diagnosis and Management.

Authors:  Rebecca Barmherzig; William Kingston
Journal:  Curr Neurol Neurosci Rep       Date:  2019-03-19       Impact factor: 5.081

Review 5.  Modelling headache and migraine and its pharmacological manipulation.

Authors:  S E Erdener; T Dalkara
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

Review 6.  Peripheral nerve stimulation for the treatment of primary headache.

Authors:  Pyungbok Lee; Billy K Huh
Journal:  Curr Pain Headache Rep       Date:  2013-03

7.  Inhibitory effect of high-frequency greater occipital nerve electrical stimulation on trigeminovascular nociceptive processing in rats.

Authors:  Olga A Lyubashina; Sergey S Panteleev; Alexey Y Sokolov
Journal:  J Neural Transm (Vienna)       Date:  2016-09-27       Impact factor: 3.575

Review 8.  The trigeminocervical complex and migraine: current concepts and synthesis.

Authors:  T Bartsch; Peter J Goadsby
Journal:  Curr Pain Headache Rep       Date:  2003-10

Review 9.  Convergence of cervical and trigeminal sensory afferents.

Authors:  Elcio J Piovesan; Pedro A Kowacs; Michael L Oshinsky
Journal:  Curr Pain Headache Rep       Date:  2003-10

10.  Neurostimulation for primary headache disorders.

Authors:  Todd J Schwedt
Journal:  Curr Neurol Neurosci Rep       Date:  2009-03       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.